Latest News about Irwin Simon
Recent news which mentions Irwin Simon
EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won't Change A Billion-Dollar Play
October 23, 2024
From Benzinga
Tilray CEO Irwin Simon: 2024 Election Likely To Drive U.S. Cannabis Legalization, No Matter Who Wins
October 10, 2024
From Benzinga
Tilray Reports $200M Q1 Net Revenue, Up 13% YoY As Net Loss Improves
October 10, 2024
From Benzinga
Two Cannabis Power Houses Team Up: Tilray Brings CBD Gummies From US Medical Marijuana Pioneer To Canada
October 07, 2024
From Benzinga
Billion-Dollar Cannabis Giant Tilray To Report Earnings, Here's What Investors Can Expect
October 01, 2024
From Benzinga
No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'
April 17, 2024
From Benzinga
Tilray CEO Irwin Simon Visits Israel To Meet Business Partners And Germany Ahead Of Imminent Legalization
December 05, 2023
From Benzinga
From Benzinga
Tilray's Trifecta: CEO Irwin Simon Says Cannabis Company Well-Positioned Around Weed, Beer, Food
October 04, 2023
Tickers
TLRY
From Benzinga
Medical Cannabis In Canada Faces Decline: What's Behind The 38% Drop In Registrations?
September 13, 2023
From Benzinga
Talking Bud: Tilray CEO On Anheuser-Busch Brands Takeover, Cannabis Legalization — 'Watch Out Because Tilray Is Coming'
August 08, 2023
From Benzinga
Tilray's HEXO Acquisition Creates Canada's Top Cannabis Company With 44% Market Share Boost
June 23, 2023
From Benzinga
Not Even Tilray Is Impervious To This Cannabis Industry Trend: Pot Giant Is Latest To Lay Off Staff
January 18, 2023
From Benzinga
Key Cannabis Exec Changes Investors Should Know About: ScottsMiracle Gro, Tilray, Metrc, & Willow Industries
November 08, 2022
From Benzinga
Jim Cramer Is Bullish On Cannabis Stocks Ahead Of Midterm Elections: 'I Say Buy Tilray'
November 08, 2022
From Benzinga
Tilray Net Loss Nearly Doubles From Year Ago, But Biden Marijuana Pardons Keep The Stock Up
October 07, 2022
Tickers
TLRY
From Benzinga
A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In Cannabis Paradise?
August 31, 2022
Tickers
TLRY
From Benzinga
EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More
July 29, 2022
From Benzinga
Tilray Will Cover Employees' Travel, Accommodation & Paid Time Off For Women Seeking Reproductive Care
June 30, 2022
From Benzinga
This Analyst Has Mixed Feelings About Tilray's Promise To Achieve $4B In Revenue By 2024, Here's Why
April 29, 2022
From Benzinga
From Benzinga
Tilray Q4 Revenue Grows 23% QoQ To $152M, Gives Update On Targeted Cost Synergies From Aphria Deal
April 06, 2022
Tickers
TLRY
From Benzinga
From Benzinga
Simon Says Legalize: Tilray CEO Makes The Case For Cannabis
March 25, 2022
Tickers
TLRY
From Benzinga
Tilray Poised To Conquer Malta's Medical Marijuana Market - Launches First Medical Cannabis Oil
March 17, 2022
Tickers
TLRY
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.